C

[C @AshokChander]

@espn @stephenasmith

@stephenasmith needs to go to journalism school. He is a degenerate sports journalist, projecting his inadequacies on his thoughtful co-hosts that put up with his Jerry Springer persona.

[C @AshokChander]

@taylorfritzfanp apologies for stepping in. We are routing for you. Go La Jolla! Go SD Tennis. #Team Fritz

[C @AshokChander]

@MRusselltennis @taylorfritzfanp as a fellow fan from SD. We are routing for you, I wonder if you add in a looping backhand with placement to move your opponent around rather than the pressure of a tight lower backhand, that may find the net?

[C @AshokChander]

@taylorfritzfanp as a fellow fan from SD. We are routing for you, I wonder if you add in a looping backhand with placement to move your opponent around rather than the pressure of a tight lower backhand, that may find the net?

[Eric Topol @EricTopol]

Just published @NEJM
During Omicron, the 2-shot mRNA vaccine effectiveness among >250,000 children age 5 to 11 years old:
vs hospitalizations was very high—83%
vs PCR confirmed infections 65%
https://t.co/7HigzbbVey

[C @AshokChander]

@SquawkCNBC for Covid guests: are they concerned Pharma is not leveraging AI / informatics to predict a pan-vaccine for Covid towards continued revenue from yearly vaccines?

[C @AshokChander]

@EricTopol @CDCgov Some detail as to J&J or Pfizer booster may be helpful.

[Eric Klein @EricKleinMD]

Bookends to a very fulfilling career: 1st RP patient (Aug 1989) still alive & cancer free @ age 88; last RP (Sep 2021) hit the trifecta 5 weeks post-op. The Emporium is now officially on hiatus. Elvis has left the building... @CleClinicUro @CleClinicNeph #TeamGUKI

[C @AshokChander]

@RexChapman @CNN please overlay this on top of the electoral college map for further digesting public health considerations and messaging

[Eric Topol @EricTopol]

Too little, too late, too flawed.
Sound familiar?
UK (and US homology) on the failure of its public health response to #COVID19
https://t.co/CgXX093t1q @bmj_latest by @GabrielScally @Bobbiedoc Kamran Abbasi

[Ajay Sudan @ajaytoo]

Congrats @shishirmehrotra and team! Coda @coda_hq now available to all. Love the new mobile experience which turns my docs into slick native apps.

[Bruce Rector, MD @BERector]

@LifeSciVC “Why are we here? We’re here to make medicines that help patients, and this conference week is supposed to rally us all around that mission. But I didn’t hear a lot about patients and impact this year.”

[George Vlasuk @GVlasuk]

@LifeSciVC “Given the speed-dating nature of most discussions, almost all JPM interactions are superficial at best.”-Amen and thanks for saying what many of us have come to realize regarding the ROI and relevance of attending JPM year after year.

[Bruce Booth @LifeSciVC]

The Game Isn’t Worth The Candle: Reflections On The JPM Healthcare Conference. More concerned than ever about the value of the JPM week and what it says about our industry. https://t.co/PBn4DvFoss #JPM19 #JPMHC19

[360Dx @360DxNews]

This Boston startup is developing technology using live cell phenotyping for the risk-stratification of #ProstateCancer @Cellanyx https://t.co/c6AFhTwPQa

[C @AshokChander]

Predicting pathology provides prostate prognostication https://t.co/mLA6EOykic

[John Harthorne @jharthorne]

Calling all #FinTech startups: applications for @MassChallengeFT are now open! @MassChallenge’s newest zero-equity accelerator can grow your #startup w/ 1:1 industry partnerships + expert mentors + up to $250K in cash. Apply by 10/12 at 12:00PM ET: https://t.co/xhvzJyF2sP

[Columbia Club of Northern California @ColumbiaNorCal]

Congrats to @Cellanyx, winner of #SDSW17 @MedStartr Pitch Fest, founded by @Columbia alum @AshokChander. https://t.co/27oF0IFVrv

[Salma Kaochar @Kaochar2]

Thank you to @theNCI @BidenCancer moonshot program for funding our initiative @BCMCancer. Thanks to @PCFnews @PCF_Science helping us lay the groundwork for this critical work on African American prostate cancer through the VA PCF Challenge Grant!

[Prostate Cancer Foundation @PCFnews]

Congratulations Jim Allison on winning the 2018 #NobelPrize in Medicine! PCF was an early funder of Allison's #immunotherapy work in #ProstateCancer. Since then, 1000's of patients have been helped, and the promising fields of immunotherapy and precision medicine have ballooned.